PL3526340T3 - Towarzysząca metoda diagnostyczna do stosowania w leczeniu zespołu jelita nadwrażliwego interwencjami dietetycznymi lub przeszczepem mikrobioty kałowej - Google Patents

Towarzysząca metoda diagnostyczna do stosowania w leczeniu zespołu jelita nadwrażliwego interwencjami dietetycznymi lub przeszczepem mikrobioty kałowej

Info

Publication number
PL3526340T3
PL3526340T3 PL17784283.8T PL17784283T PL3526340T3 PL 3526340 T3 PL3526340 T3 PL 3526340T3 PL 17784283 T PL17784283 T PL 17784283T PL 3526340 T3 PL3526340 T3 PL 3526340T3
Authority
PL
Poland
Prior art keywords
treatment
diagnostic method
bowel syndrome
irritable bowel
companion diagnostic
Prior art date
Application number
PL17784283.8T
Other languages
English (en)
Inventor
Finn Terje HEGGE
Christina CASEN
Jørgen VALEUR
Arne RØSETH
Milada Cvancarova SMÅSTUEN
Original Assignee
Genetic Analysis As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetic Analysis As filed Critical Genetic Analysis As
Publication of PL3526340T3 publication Critical patent/PL3526340T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/10—Enterobacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL17784283.8T 2016-10-14 2017-10-13 Towarzysząca metoda diagnostyczna do stosowania w leczeniu zespołu jelita nadwrażliwego interwencjami dietetycznymi lub przeszczepem mikrobioty kałowej PL3526340T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1617519.2A GB201617519D0 (en) 2016-10-14 2016-10-14 A companion diagnostic method for use in the treatment of irritable bowel syndrome with dietary interventions or faecal microbiota transplant
PCT/EP2017/076261 WO2018069538A1 (en) 2016-10-14 2017-10-13 A companion diagnostic method for use in the treatment of irritable bowel syndrome with dietary interventions or faecal microbiota transplant

Publications (1)

Publication Number Publication Date
PL3526340T3 true PL3526340T3 (pl) 2024-08-26

Family

ID=57680683

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17784283.8T PL3526340T3 (pl) 2016-10-14 2017-10-13 Towarzysząca metoda diagnostyczna do stosowania w leczeniu zespołu jelita nadwrażliwego interwencjami dietetycznymi lub przeszczepem mikrobioty kałowej

Country Status (12)

Country Link
US (3) US10794909B2 (pl)
EP (1) EP3526340B1 (pl)
JP (1) JP7100045B2 (pl)
CN (1) CN110114471A (pl)
AU (1) AU2017342088B2 (pl)
BR (1) BR112019007424A2 (pl)
CA (1) CA3039144A1 (pl)
ES (1) ES2983641T3 (pl)
GB (1) GB201617519D0 (pl)
MX (1) MX2019004207A (pl)
PL (1) PL3526340T3 (pl)
WO (1) WO2018069538A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201617519D0 (en) 2016-10-14 2016-11-30 Genetic Analysis As A companion diagnostic method for use in the treatment of irritable bowel syndrome with dietary interventions or faecal microbiota transplant
CN115252652B (zh) * 2017-09-11 2025-09-16 广州知易生物科技有限公司 脆弱拟杆菌在制备防治肠易激综合征的药物中的应用
CN111261238A (zh) * 2020-01-15 2020-06-09 生态环境部南京环境科学研究所 PPCPs类有机化学品中温厌氧消化去除率预测模型的构建方法
EP3913371A1 (en) 2020-05-18 2021-11-24 Neuroimmun GmbH Method and kit for diagnosting irritable bowel syndrome and for its relief through dietary interventions
CN114686557A (zh) * 2022-03-07 2022-07-01 中国农业大学 用于评估食物过敏的肠道菌群生物标志物及其用途和试剂盒
CN117106893A (zh) * 2023-08-28 2023-11-24 中国人民解放军总医院第二医学中心 用于粪菌移植的肠易激综合征肠道微生物标志物及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9709728D0 (en) 1997-05-13 1997-07-02 Dynal As Single step method
GB0001450D0 (en) 2000-01-21 2000-03-08 Genpoint As Cell isolation method
PT1940243E (pt) 2005-10-24 2011-10-17 Nestec Sa Formulação de fibras alimentares e método de administração
CA2776420A1 (en) * 2009-10-05 2011-04-14 Aak Patent B.V. Methods for diagnosing irritable bowel syndrome
GB201021399D0 (en) * 2010-12-16 2011-01-26 Genetic Analysis As Oligonucleotide probe set and methods of microbiota profiling
US10130665B2 (en) 2012-05-18 2018-11-20 Genome Research Limited Method for identifying bacteria for bacteriotherapy
CA2947962C (en) * 2014-05-04 2024-01-16 Salix Pharmaceuticals, Inc. Ibs microbiota and uses thereof
US20160346303A1 (en) * 2014-10-29 2016-12-01 Glycom A/S Synthetic composition and method for treating irritable bowel syndrome
GB201505364D0 (en) * 2015-03-27 2015-05-13 Genetic Analysis As Method for determining gastrointestinal tract dysbiosis
CN105543385B (zh) 2016-01-29 2024-12-06 山东大学齐鲁医院 肠易激综合征微生物标志物及其应用
GB201617519D0 (en) 2016-10-14 2016-11-30 Genetic Analysis As A companion diagnostic method for use in the treatment of irritable bowel syndrome with dietary interventions or faecal microbiota transplant

Also Published As

Publication number Publication date
JP2019531096A (ja) 2019-10-31
RU2762266C1 (ru) 2021-12-17
US12596121B2 (en) 2026-04-07
US20200400666A1 (en) 2020-12-24
US10794909B2 (en) 2020-10-06
CA3039144A1 (en) 2018-04-19
US20220120747A1 (en) 2022-04-21
US20200049708A1 (en) 2020-02-13
BR112019007424A2 (pt) 2019-07-02
EP3526340B1 (en) 2024-06-26
CN110114471A (zh) 2019-08-09
US11243203B2 (en) 2022-02-08
JP7100045B2 (ja) 2022-07-12
GB201617519D0 (en) 2016-11-30
AU2017342088B2 (en) 2023-11-16
MX2019004207A (es) 2019-09-26
AU2017342088A1 (en) 2019-05-02
ES2983641T3 (es) 2024-10-24
WO2018069538A1 (en) 2018-04-19
EP3526340A1 (en) 2019-08-21

Similar Documents

Publication Publication Date Title
PL3223835T3 (pl) Mikrobiota jelitowa i gvhd
PL3212208T3 (pl) Zastosowanie bakterii l. reuteri do zapobiegania lub leczenia dysbiozy mikrobioty we wczesnych fazach życia
GB201617519D0 (en) A companion diagnostic method for use in the treatment of irritable bowel syndrome with dietary interventions or faecal microbiota transplant
EP3092482A4 (en) Ultrasound diagnostic apparatus and method of operating the same
EP3173027A4 (en) Heart failure evaluation method and diagnosis device
EP3169228A4 (en) Device and method suitable for monitoring arterial blood in body part
EP3166688A4 (en) Tau imaging ligands and their uses in the diagnosis and treatment of tauopathy
GB201413357D0 (en) Antibodies for treatment and diagnosis
SG11201703704PA (en) Diagnosis and treatment of incipient diabetes
SG11201700087UA (en) On-site diagnostic system and the method thereof
PT3334761T (pt) Moléculas baseadas em anticorpo seletivo para o epítopo {p}ser404 da tau e os seus usos no diagnóstico e tratamento de tauopatias
GB201500875D0 (en) Antibodies for treatment and diagnosis
EP3137907A4 (en) Methods and compositions for the diagnosis and treatment of kawasaki disease
IL248210A0 (en) Methods and preparations for the treatment of blood vessel malformations
GB201504387D0 (en) Materials and methods for the treatment of vascular disease
SG11201700537VA (en) Compounds against ralstonia pickettii for use in the treatment of insulin resistance, and method of diagnosis of insulin resistance
PL3232998T3 (pl) Urządzenie medyczne do wykonywania ileostomii i/albo jejunostomii
EP3229693A4 (en) Ultrasound diagnostic apparatus and method of operating the same
EP3116404A4 (en) Medical diagnostic apparatus and operating method thereof
IL248935A0 (en) Diagnostic testing and treatment/prevention of Alzheimer's disease
EP2997969A4 (en) Treatment agent and treatment method for intestinal examination or surgery
GB201510676D0 (en) Novel diagnostic and therapeutic method
PT3548006T (pt) Composição para utilização no tratamento de alterações intestinais
EP3188744A4 (en) Methods for treatment and prevention of vascular disease
EP3194984A4 (en) In-vitro diagnostic apparatus and in-vitro diagnostic method performed by in-vitro diagnostic apparatus